Karyopharm Drug Patent Portfolio
Karyopharm owns 1 orange book drug protected by 11 US patents Given below is the list of Karyopharm's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10519139 | Polymorphs of Selinexor | 14 Aug, 2035 | Active |
| US11746102 | Polymorphs of selinexor | 14 Aug, 2035 | Active |
| US11753401 | Polymorphs of Selinexor | 14 Aug, 2035 | Active |
| US11807629 | Polymorphs of Selinexor | 14 Aug, 2035 | Active |
| US8999996 | Hydrazide containing nuclear transport modulators and uses thereof | 03 Jul, 2033 | Active |
| US10544108 | Hydrazide containing nuclear transport modulators and uses thereof | 26 Jul, 2032 | Active |
| US11034660 | Hydrazide containing nuclear transport modulators and uses thereof | 26 Jul, 2032 | Active |
| US11787771 | Hydrazide containing nuclear transport modulators and uses thereof | 26 Jul, 2032 | Active |
| US12291508 | Hydrazide containing nuclear transport modulators and uses thereof | 26 Jul, 2032 | Active |
| US9079865 | Hydrazide containing nuclear transport modulators and uses thereof | 26 Jul, 2032 | Active |
| US9714226 | Hydrazide containing nuclear transport modulators and uses thereof | 26 Jul, 2032 | Active |
Latest Legal Activities on Karyopharm's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Karyopharm.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Email Notification | 24 Jun, 2025 | US12291508 |
| Mail Patent eCofC Notification | 24 Jun, 2025 | US12291508 |
| Recordation of Patent eCertificate of Correction | 24 Jun, 2025 | US12291508 |
| Patent eCofC Notification | 24 Jun, 2025 | US12291508 |
| Mail Certificate of Correction Memo | 03 Jun, 2025 | US12291508 |
| Certificate of Correction Memo | 31 May, 2025 | US12291508 |
| Patent Issue Date Used in PTA Calculation | 06 May, 2025 | US12291508 |
| Recordation of Patent eGrant | 06 May, 2025 | US12291508 |
| Patent eGrant Notification | 06 May, 2025 | US12291508 |
| Mail Patent eGrant Notification | 06 May, 2025 | US12291508 |
| Email Notification | 06 May, 2025 | US12291508 |
| Recordation of Patent Grant Mailed | 06 May, 2025 | US12291508 |
| Email Notification | 17 Apr, 2025 | US12291508 |
| Issue Notification Mailed | 16 Apr, 2025 | US12291508 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 11 Apr, 2025 | US9714226 |
Karyopharm's Family Patents
Karyopharm drugs have patent protection in a total of 37 countries. It's US patent count contributes only to 22.5% of its total global patent coverage. Click
below to unlock the full patent family tree.
Karyopharm Drug List
Given below is the complete list of Karyopharm's drugs and the patents protecting them.
1. Xpovio
Xpovio is protected by 11 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10519139 | Polymorphs of Selinexor |
14 Aug, 2035
(9 years from now)
| Active |
| US11746102 | Polymorphs of selinexor |
14 Aug, 2035
(9 years from now)
| Active |
| US11753401 | Polymorphs of Selinexor |
14 Aug, 2035
(9 years from now)
| Active |
| US11807629 | Polymorphs of Selinexor |
14 Aug, 2035
(9 years from now)
| Active |
| US8999996 | Hydrazide containing nuclear transport modulators and uses thereof |
03 Jul, 2033
(7 years from now)
| Active |
| US10544108 | Hydrazide containing nuclear transport modulators and uses thereof |
26 Jul, 2032
(6 years from now)
| Active |
| US11034660 | Hydrazide containing nuclear transport modulators and uses thereof |
26 Jul, 2032
(6 years from now)
| Active |
| US11787771 | Hydrazide containing nuclear transport modulators and uses thereof |
26 Jul, 2032
(6 years from now)
| Active |
| US12291508 | Hydrazide containing nuclear transport modulators and uses thereof |
26 Jul, 2032
(6 years from now)
| Active |
| US9079865 | Hydrazide containing nuclear transport modulators and uses thereof |
26 Jul, 2032
(6 years from now)
| Active |
| US9714226 | Hydrazide containing nuclear transport modulators and uses thereof |
26 Jul, 2032
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xpovio's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List